Current Issue
Cover Story
Benchmarking HME
Do you know whether your home medical equipment business is being run efficiently and profitably?
Recent Popular Articles
advertisement
Quick Links
HomeCareXtra
Cover Story
Getting Back To Business
The effects of Medicare's competitive bidding delay are a complicated matter.
Classic Articles
Marketplace
advertisement
advertisement
advertisement
advertisement
ProviderNews
In Home Health Records 76 Percent Jump in Net Income Minnetonka, Minn. Leaps in both revenue and profit margins resulted in a 76 percent jump in net income recorded by In Home Health for the first quarter of fiscal 2000 ended Dec. 31. For the quarter, the company posted net income of $910,000, or 5 cents a share, compared with net income of $517,000, or a loss of 2 cents a share, a year ago.
Revenue for the quarter increased 23 percent, to $22.8 million from $18.6 million the previous year. Officials attributed the growth in part to the acquisition of six home health agencies during the quarter.
Wolfgang von Maack, chairman and chief executive officer, said the company is "developing strategies for a successful transition to [the prospective payment system]." And he added, "We continue to prudently evaluate acquisition opportunities where we can leverage our existing resources and remain steadfast in our commitment to providing quality services to patients, focusing our efforts on expanding business, which allows us to achieve higher margins." -S.H.
Bergen Brunswig Q1Net Income Falls, Stadtlander Results Blamed Orange, Calif. Bergen Brunswig's net income for the first quarter of fiscal 2000 ended Dec. 31 fell nearly 48 percent to $14.7 million, or 11 cents a diluted share, from $27.9 million, or 27 cents a share, the previous year. Revenue was $4.8 billion for the quarter compared with $4 billion the year before.
Company chairman and chief executive officer Robert Martini said he was disappointed that the company would not meet its fiscal 2000 earnings-per-share growth objective, which analysts had predicted at 86 cents a share. "We are not satisfied with our year-over-year earnings decline and continue to pursue corrective actions to restore our profitability to acceptable levels," he said. He added that poor results at Stadtlander, a pharmaceutical services company that Bergen purchased last year for $400 million, had depressed earnings. The company is restructuring the Stadtlander unit to cut costs, Martini said, and it is exploring strategic possibilities for the subsidiary.-S.H.
Want to use this article? Click here for options!
© 2008 Penton Media Inc.






